These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
270 related items for PubMed ID: 28072975
1. [Molecular features of metanephric adenoma and their values in differential diagnosis]. Wang X, Shi SS, Yang WR, Ye SB, Li R, Ma HH, Zhang RS, Lu ZF, Zhou XJ, Rao Q. Zhonghua Bing Li Xue Za Zhi; 2017 Jan 08; 46(1):38-42. PubMed ID: 28072975 [Abstract] [Full Text] [Related]
6. [Expression of cadherin17 in metanephric adenoma and its value in differential diagnosis]. Wang X, Wu N, Yang WR, Shi SS, Ma HH, Wei X, Zhou XJ, Rao Q. Zhonghua Bing Li Xue Za Zhi; 2016 Jul 08; 45(7):457-61. PubMed ID: 27430690 [Abstract] [Full Text] [Related]
7. Molecular characterisation of metanephric adenomas beyond BRAF: genetic evidence for potential malignant evolution. Chan E, Stohr BA, Croom NA, Cho SJ, Garg K, Troxell ML, Higgins JP, Bean GR. Histopathology; 2020 Jun 08; 76(7):1084-1090. PubMed ID: 32064677 [Abstract] [Full Text] [Related]
8. Molecular Characterization of Metanephric Adenoma, Epithelial Wilms Tumor, and Overlap Lesions: An Integrated Whole-exome and Transcriptome Sequencing Analysis. Pan CC, Tseng CE, Kuroda N, Yano M, Yasuda M, Nagashima Y, Yeh YC, Wang YC, Chang YH, Epstein JI. Appl Immunohistochem Mol Morphol; 2022 Apr 01; 30(4):257-263. PubMed ID: 35384875 [Abstract] [Full Text] [Related]
11. Immunohistochemistry with Anti-BRAF V600E (VE1) Mouse Monoclonal Antibody is a Sensitive Method for Detection of the BRAF V600E Mutation in Colon Cancer: Evaluation of 120 Cases with and without KRAS Mutation and Literature Review. Dvorak K, Higgins A, Palting J, Cohen M, Brunhoeber P. Pathol Oncol Res; 2019 Jan 01; 25(1):349-359. PubMed ID: 29127628 [Abstract] [Full Text] [Related]
12. A renal metanephric adenoma showing both a 2p16e24 deletion and BRAF V600E mutation: a synergistic role for a tumor suppressor gene on chromosome 2p and BRAF activation? Dadone B, Ambrosetti D, Carpentier X, Duranton-Tanneur V, Burel-Vandenbos F, Amiel J, Pedeutour F. Cancer Genet; 2013 Jan 01; 206(9-10):347-52. PubMed ID: 24432405 [Abstract] [Full Text] [Related]
15. Assessment of BRAF V600E Status in Colorectal Carcinoma: Tissue-Specific Discordances between Immunohistochemistry and Sequencing. Estrella JS, Tetzlaff MT, Bassett RL, Patel KP, Williams MD, Curry JL, Rashid A, Hamilton SR, Broaddus RR. Mol Cancer Ther; 2015 Dec 01; 14(12):2887-95. PubMed ID: 26438153 [Abstract] [Full Text] [Related]
17. Detection of the BRAF V600E mutation in serous ovarian tumors: a comparative analysis of immunohistochemistry with a mutation-specific monoclonal antibody and allele-specific PCR. Bösmüller H, Fischer A, Pham DL, Fehm T, Capper D, von Deimling A, Bonzheim I, Staebler A, Fend F. Hum Pathol; 2013 Mar 01; 44(3):329-35. PubMed ID: 23089489 [Abstract] [Full Text] [Related]